Pramlintide (SymlinPen)

FDA-approved product existsMetabolic ResearchWeight & metabolic

Awaiting review, BioHarmony verdict

Not yet scored. Queued for review; until then rely on the status and sources below.

What is Pramlintide (SymlinPen)?

Pramlintide was FDA approved as Symlin and SymlinPen as an adjunct to mealtime insulin in patients with type 1 or type 2 diabetes who have not achieved desired glucose control despite optimal insulin therapy. Drugs@FDA now lists every Symlin presentation as discontinued, and the DailyMed listing records a marketing end date of January 31, 2027.

Saved on this device only.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

Approved labelSYMLINPEN prescribing information as an adjunct to mealtime insulin; Drugs@FDA lists the product as discontinued
PopulationAdults with type 1 or type 2 diabetes covered by the approved indication
DoseType 1 diabetes starts at 15 mcg before major meals with label-directed 15 mcg increases. Type 2 diabetes starts at 60 mcg before major meals and may increase to 120 mcg if tolerated. The label also directs a 50% initial reduction in mealtime insulin.
RouteSubcutaneous injection in the abdomen or thigh, separate from insulin injections
FrequencyImmediately before major meals containing at least 250 calories or 30 grams of carbohydrate
DurationLong-term adjunctive use with label-directed glucose monitoring and titration
PreparationReady-to-use 1000 mcg/mL solution in SymlinPen 60 and SymlinPen 120 multidose pens; no reconstitution.
Source: Dosage and Administration sections 2.1-2.6; Dosage Forms and Strengths section 3

Working with a vial? The reconstitution calculator covers mixing math, not dosing advice.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalFDA-approved product exists
CompoundingFDA-approved product is listed as discontinued; compounded copies are not FDA approved

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.